Inventor
Guixue Yu
Inventor
Princeton Junction, NJ, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes15%
C07KPeptides5%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
8,557,841'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20138,232,291'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20127,977,353'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20117,910,601'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20117,816,357'Azabicyclic heterocycles as cannabinoid receptor modulators'20107,799,801'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20107,592,354'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20097,589,102'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20097,384,958'Quinoline inhibitors of cGMP phosphodiesterase'20087,378,430'Quinoline inhibitors of cGMP phosphodiesterase'20087,378,418'Azabicyclic heterocycles as cannabinoid receptor modulators'20087,317,012'Bicyclic heterocycles as cannabinoind-1 receptor modulators'20087,173,042'Quinoline inhibitors of cGMP phosphodiesterase'20077,166,603'Dihydropyrimidone inhibitors of calcium channel function'20077,166,596'Heterocyclic aromatic compounds useful as growth hormone secretagogues'20077,067,525'Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same'20067,037,910'Azabicyclic heterocycles as cannabinoid receptor modulators'20066,979,691'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20056,835,737'Quinoline inhibitors of cGMP phosphodiesterase'20046,713,487'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20046,576,644'Quinoline inhibitors of cGMP phosphodiesterase'20036,326,379'Fused pyridine inhibitors of cGMP phosphodiesterase'20016,316,438'Fused pyridopyridazine inhibitors of cGMP phosphodiesterase'20015,726,195'Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998Based in Wakefield, MA, US· patent location history
2001–2013Patents assigned to BRISTOL MYERS SQUIBB CO (22)· patent assignee history
2001Based in West Caldwell, NJ, US· patent location history
2001Based in West Windsor, NJ, US· patent location history
2003–2008Based in Lawrenceville, NJ, US· patent location history
2006–2013Based in Princeton Junction, NJ, US· patent location history
2012–2013Patents assigned to EWING WILLIAM R (2)· patent assignee history
2012–2013Patents assigned to LI JAMES J (2)· patent assignee history
2012–2013Patents assigned to LI JUN (2)· patent assignee history
2012–2013Patents assigned to SULSKY RICHARD B (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 22 | 2001–2013 |
| EWING WILLIAM R | 2 | 2012–2013 |
| LI JAMES J | 2 | 2012–2013 |
| LI JUN | 2 | 2012–2013 |
| SULSKY RICHARD B | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Princeton Junction, New Jersey, US | 12 | 2006–2013 |
| Lawrenceville, New Jersey, US | 9 | 2003–2008 |
| West Caldwell, New Jersey, US | 1 | 2001 |
| West Windsor, New Jersey, US | 1 | 2001 |
| Wakefield, Massachusetts, US | 1 | 1998 |